Vanda Pharmaceuticals
VNDA
#8782
Rank
NZ$0.41 B
Marketcap
NZ$6.89
Share price
6.41%
Change (1 day)
-11.92%
Change (1 year)

Vanda Pharmaceuticals (VNDA) - Cash on Hand

Cash on Hand as of June 2026 : NZ$0.30 Billion

According to Vanda Pharmaceuticals's latest financial reports the company has NZ$0.30 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Vanda Pharmaceuticals - Cash on Hand chart (from 2005 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31NZ$0.45 B-31.42%
2024-12-31NZ$0.66 B8.2%
2023-12-31NZ$0.61 B-16.51%
2022-12-31NZ$0.73 B16.05%
2021-12-31NZ$0.63 B24.33%
2020-12-31NZ$0.50 B9.97%
2019-12-31NZ$0.46 B20.79%
2018-12-31NZ$0.38 B90%
2017-12-31NZ$0.20 B-1.04%
2016-12-31NZ$0.20 B-2.46%
2015-12-31NZ$0.20 B26.26%
2014-12-31NZ$0.16 B4.46%
2013-12-31NZ$0.15 B8.38%
2012-12-31NZ$0.14 B-23.28%
2011-12-31NZ$0.19 B-25.68%
2010-12-31NZ$0.25 B-9.18%
2009-12-31NZ$0.28 B253.06%
2008-12-31NZ$80.05 M-28%
2007-12-31NZ$0.11 B145.79%
2006-12-31NZ$45.23 M-0.75%
2005-12-31NZ$45.58 M100.03%
2004-12-31NZ$22.78 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
NZ$31.05 B 10,032.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$16.17 B 5,178.51%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$21.08 B 6,780.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$8.80 B 2,773.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.87 B 4,099.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$22.67 B 7,299.33%๐Ÿ‡บ๐Ÿ‡ธ USA